Concr at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

Concr brings 2 presentations to ENA 2026 in Barcelona. Its posters test multimodal digital twins against standard ways of choosing treatment for patients. In pancreatic cancer the model beats conventional biomarker stratification, and in triple-negative breast cancer it predicts response to the chemotherapy backbone to uncover who benefits from immunotherapy.

OrganizationENA 2026 Attendance
Concr
London, UK
Tools, data & diagnostics
Builds AI digital-twin models of cancer patients to predict treatment response for trials and drug development.

Explore the full ENA 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Barcelona. Leave your work email and we’ll be in touch.

Privacy

Download the full ENA 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Concr

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction